Home

Our mission

Providing custom tailored, high quality preclinical services to prime your drugs for success.

WHY US

We offer expert solutions for optimal preclinical testing

  • standardized efficacy evaluation platforms
  • long standing expertise in preclinical testing
  • humanized precision models
  • unique animal models mimicking the complexity of human disease
  • over 100 therapeutics successfully tested
  • scientific excellence

LATEST NEWS & BLOG

Biomedcode is pleased to announce that it has received national funding from the General Secretary for Research and Technology supporting the innovative research networks HUPLA and BreasCaRANKL that combine the efforts of industrial and renowned academic partners to develop precision drug evaluation tools  for the preclinical development of novel therapies for Multiple Sclerosis and Breast Cancer.

PRECLINICAL SERVICES DELIVERED

80

CLIENTS

230

CONTRACTS

110

THERAPEUTICS TESTED

27

COUNTRIES

OUR CLIENTS SAY

Clients